ICD아이씨디
040910 · KOSDAQ · ₩040910 · 아이씨디
₩3,700▼ ₩70 (1.86%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩29B | ₩22B | ₩52B | ₩42B | ₩86B | ₩17B | ₩62B | ₩32B |
| Cost of sales | ₩21B | ₩21B | ₩39B | ₩36B | ₩72B | ₩17B | ₩62B | ₩31B |
| Gross profit | ₩7.6B | ₩1.2B | ₩13B | ₩5.5B | ₩14B | ₩735M | ₩621M | ₩1B |
| Operating income | ₩1.8B | −₩5B | ₩4.2B | −₩338M | ₩7.6B | −₩7B | −₩9.8B | −₩3.1B |
| Net income | ₩4.5B | −₩3.6B | ₩4.7B | ₩223M | ₩84M | −₩7B | −₩18B | −₩838M |
| Net income to shareholders | ₩4.6B | −₩3.6B | ₩4.7B | ₩243M | ₩109M | −₩6.9B | −₩18B | −₩833M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩195B | ₩177B | ₩144B | ₩155B | ₩191B | ₩196B | ₩191B | ₩228B |
| Current assets | ₩131B | ₩113B | ₩80B | ₩91B | ₩125B | ₩126B | ₩120B | ₩143B |
| Cash and equivalents | ₩23B | ₩16B | ₩8.4B | ₩15B | ₩20B | ₩20B | ₩23B | ₩25B |
| Total liabilities | ₩96B | ₩82B | ₩46B | ₩61B | ₩98B | ₩106B | ₩94B | ₩107B |
| Current liabilities | ₩92B | ₩79B | ₩43B | ₩56B | ₩93B | ₩97B | ₩78B | ₩93B |
| Borrowings | ₩29B | ₩18B | ₩18B | ₩20B | ₩21B | ₩36B | ₩33B | ₩33B |
| Total equity | ₩99B | ₩95B | ₩98B | ₩94B | ₩93B | ₩90B | ₩97B | ₩121B |
| Shareholders' equity | ₩99B | ₩95B | ₩99B | ₩94B | ₩93B | ₩90B | ₩97B | ₩121B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩17B | ₩8.9B | −₩4.2B | −₩5.7B | ₩29B | −₩11B | −₩852M | −₩3.1B |
| Capital spending | ₩224M | ₩284M | ₩30M | ₩289M | — | — | — | ₩53M |
| Free cash flow | −₩17B | ₩8.6B | −₩4.2B | −₩6B | ₩29B | −₩11B | −₩852M | −₩3.2B |
Consolidated where available. Amounts in won.
Also known as: ICD / 아이씨디 / 040910 / KRX:040910
Source: KRX statistical information